[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Otoacoustic Emissions and Anticholinergics
- To: AUDITORY@xxxxxxxxxxxxxxx
- Subject: Re: Otoacoustic Emissions and Anticholinergics
- From: Sam Reyes <reyes@xxxxxxxxxxxxx>
- Date: Fri, 19 Nov 2004 11:00:57 -0500
- Delivery-date: Fri Nov 19 11:31:57 2004
- In-reply-to: <200411180501.iAI50oE7001179@mailscan2.cc.mcgill.ca>
- Reply-to: Sam Reyes <reyes@xxxxxxxxxxxxx>
- Sender: AUDITORY Research in Auditory Perception <AUDITORY@xxxxxxxxxxxxxxx>
- Thread-index: AcTNLBlNbqpTbErORYi/uWwBOkE7lABIu0dw
A quick pubmed search came up with these:
Drexl M et al. Hear Res. 2004 Aug;194(1-2):135-42.
Di Girolamo S et al. Hear Res. 2001 Dec;162(1-2):80-4.
Paludetti G et al. Acta Otolaryngol. 2001 Jan;121(2):119-21.
Kujawa SG et al. Hear Res. 1992 Aug;61(1-2):106-16.
The abstract from the DiGirolamo article mentions possibly using DPOAEs to
diagnose myasthenia gravis and monitor treatment (AChE inhibitors). I
didn't seen anything on Lasix, but I assumed its effect was mediated by
changing the endolymphatic potential.
---sam